ALX Oncology
(NASDAQ) ALXO
ALX Oncology Financials at a Glance
Market Cap
$259.27M
Revenue (TTM)
$0.00
Net Income (TTM)
$101.69M
EPS (TTM)
$-1.90
P/E Ratio
-1.04
Dividend
$0.00
Beta (Volatility)
1.52 (High)
Dividend
$0.00
Beta (Volatility)
1.52 (High)
Price
$2.00
Volume
415,130
Open
$1.94
Price
$2.00
Volume
415,130
Open
$1.94
Previous Close
$1.97
Daily Range
$1.94 - $2.04
52-Week Range
$0.40 - $2.66
Dividend
$0.00
Beta (Volatility)
1.52 (High)
Price
$2.00
Volume
415,130
Open
$1.94
Previous Close
$1.97
Daily Range
$1.94 - $2.04
52-Week Range
$0.40 - $2.66
ALXO News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout ALX Oncology
Industry
Biotechnology
Sector
Health CareEmployees
43
CEO
Jason Lettmann, MBA
Website
www.alxoncology.comHeadquarters
South San Francisco, CA 94080, US
ALXO Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
0%
Net Income Margin
0%
Return on Equity
-146%
Return on Capital
-3%
Return on Assets
-2%
Earnings Yield
-96.15%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$259.27M
Shares Outstanding
131.61M
Volume
415.13K
Short Interest
0.00%
Avg. Volume
684.39K
Financials (TTM)
Gross Profit
$0.00
Operating Income
$100.85M
EBITDA
$100.85M
Operating Cash Flow
$84.14M
Capital Expenditure
$212.00K
Free Cash Flow
$84.35M
Cash & ST Invst.
$44.79M
Total Debt
$5.22M
ALX Oncology Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
$0.00
N/A
Gross Margin
0.00%
N/A
Market Cap
$259.27M
N/A
Market Cap/Employee
$3.99M
N/A
Employees
65
N/A
Net Income
$22.85M
+21.7%
EBITDA
$23.02M
+19.3%
Quarterly Fundamentals
Net Cash
$39.57M
-66.4%
Accounts Receivable
$298.00K
N/A
Inventory
$0.00
N/A
Long Term Debt
$0.00
-100.0%
Short Term Debt
$5.22M
+1099.3%
Return on Assets
-1.72%
N/A
Return on Invested Capital
-3.02%
N/A
Free Cash Flow
$19.03M
+40.7%
Operating Cash Flow
$18.98M
+40.8%